- Journal Article
© 2020 Frederick Furness Publishing Ltd. Ever-increasing interest in device platforms raises concerns around the broad availability of lookalike autoinjectors that may result in inappropriate medication usage and potentially put patients at risk. Here, Andreas Schneider, PhD, Innovation & Business Development Manager, Ypsomed Delivery Systems, summarises a recent empirical study1 detailing how effectively various user groups distinguished platform device variants. The article highlights how patients, healthcare professionals and non-professional caregivers distinguished between device versions, provides insights into which device attributes drive device distinguishability, and then relates these attributes to user group-specific characteristics. Show more
Journal / seriesONdrugDelivery
Pages / Article No.
PublisherFrederick Furness Publishing Ltd
MoreShow all metadata